On the occasion of the 5th annual conference on the regulation of ATMPs on 16 December 2016 in London, some presenters spoke to us on their work and their thoughts on how to improve access for patients to these potentially curative medicines.
While awaiting the meeting report, hear from three key people participating in the discussions:
Martine Pergent, IPOPI, Salah-Dine Chibout, Novartis Institute for Biomedical Research for IMI and
Andrea Chiesi, EBE Vice-President, of Chiesi Farmaceutici.
The program and presentations are available here and on the EMA website here.
Listen here to Martine Pergent, IPOPI and Salah-Dine Chibout, Novartis. Listen here to Andrea Chiesi, EBE Vice-President, Chiesi Farmaceutici.